EDSA
Income statement / Annual
Last year (2024), Edesa Biotech, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Edesa Biotech, Inc.'s net income was -$6.17 M.
See Edesa Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$328.80 K |
$410.87 K |
$211.85 K |
$228.29 K |
$1.27 M |
$758.69 K |
| Cost of Revenue |
$186.05 K
|
$183.47 K
|
$118.19 K
|
$118.79 K
|
$17.60 K
|
$101.29 K
|
$445.32 K
|
$534.45 K
|
$1.13 M
|
$840.25 K
|
| Gross Profit |
-$186.05 K
|
-$183.47 K
|
-$118.19 K
|
-$118.79 K
|
$311.20 K
|
$309.58 K
|
-$233.47 K
|
-$306.17 K
|
$143.86 K
|
-$81.56 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0.95
|
0.75
|
-1.1
|
-1.34
|
0.11
|
-0.11
|
| Research and Development Expenses |
$2.88 M
|
$4.79 M
|
$13.34 M
|
$17.95 M
|
$3.33 M
|
$1.10 M
|
$2.09 M
|
$1.97 M
|
$1.73 M
|
$1.03 M
|
| General & Administrative Expenses |
$4.13 M
|
$4.43 M
|
$5.04 M
|
$5.73 M
|
$3.38 M
|
$2.05 M
|
$2.76 M
|
$2.94 M
|
$3.32 M
|
$3.23 M
|
| Selling & Marketing Expenses |
$0.00
|
-$183.47 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.13 M
|
$4.24 M
|
$5.04 M
|
$5.73 M
|
$3.38 M
|
$2.05 M
|
$2.76 M
|
$2.94 M
|
$3.32 M
|
$3.23 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$780.26 K
|
-$10.34 M
|
$37.41 K
|
$0.00
|
$0.00
|
$0.00
|
$24.63 K
|
$0.00
|
| Operating Expenses |
$7.01 M
|
$9.22 M
|
$17.59 M
|
$13.34 M
|
$6.71 M
|
$3.14 M
|
$4.84 M
|
$4.92 M
|
$5.05 M
|
$4.26 M
|
| Cost And Expenses |
$7.01 M
|
$9.22 M
|
$17.59 M
|
$13.34 M
|
$6.73 M
|
$3.24 M
|
$5.29 M
|
$5.45 M
|
$6.18 M
|
$5.10 M
|
| Interest Income |
$153.50 K
|
$289.85 K
|
$63.52
|
$11.17 K
|
$37.78 K
|
$56.84 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$186.05 K
|
$183.47 K
|
$118.19 K
|
$118.79 K
|
$57.56 K
|
$6.37 K
|
$188.37 K
|
$179.32 K
|
$149.57 K
|
$159.52 K
|
| EBITDA |
-$5.98 M |
-$8.19 M |
-$17.43 M |
-$13.22 M |
-$6.35 M |
-$2.83 M |
-$4.85 M |
-$4.85 M |
-$4.87 M |
-$2.65 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-19.3
|
-6.88
|
-22.89
|
-21.25
|
-3.83
|
-3.49
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-19.47
|
-6.89
|
-23.97
|
-22.89
|
-3.86
|
-5.72
|
| Total Other Income/Expenses Net |
$845.50 K
|
$849.14 K
|
$822.67 K
|
$10.34 M
|
$37.41 K
|
-$309.45 K
|
$40.10 K
|
$194.70 K
|
-$110.52 K
|
$1.53 M
|
| Income Before Tax |
-$6.17 M
|
-$8.37 M
|
-$17.55 M
|
-$13.34 M
|
-$6.36 M
|
-$2.78 M
|
-$5.04 M
|
-$5.03 M
|
-$5.02 M
|
-$2.81 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-19.35
|
-6.76
|
-23.78
|
-22.03
|
-3.95
|
-3.7
|
| Income Tax Expense |
$800.00
|
$800.00
|
$800.00
|
$800.00
|
$800.00
|
-$55.40 K
|
$800.00
|
$800.00
|
$7.20 K
|
$36.80 K
|
| Net Income |
-$6.17 M
|
-$8.37 M
|
-$17.55 M
|
-$13.34 M
|
-$6.36 M
|
-$2.72 M
|
-$5.04 M
|
-$5.03 M
|
-$5.03 M
|
-$2.84 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-19.36
|
-6.62
|
-23.79
|
-22.04
|
-3.95
|
-3.75
|
| EPS |
-1.93 |
-2.93 |
-8.37 |
-7.74 |
-5.18 |
-4.15 |
-10.54 |
-218.72 |
-23.92 |
-15.01 |
| EPS Diluted |
-1.93 |
-2.93 |
-8.37 |
-7.73 |
-5.18 |
-4.15 |
-10.54 |
-211.28 |
-23.92 |
-15.01 |
| Weighted Average Shares Out |
$3.20 M
|
$2.86 M
|
$2.10 M
|
$1.73 M
|
$1.23 M
|
$655.00 K
|
$478.23 K
|
$23.00 K
|
$210.15 K
|
$189.45 K
|
| Weighted Average Shares Out Diluted |
$3.20 M
|
$2.86 M
|
$2.10 M
|
$1.73 M
|
$1.23 M
|
$655.32 K
|
$478.23 K
|
$23.81 K
|
$210.15 K
|
$189.45 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
